Biomarker Expression in HepG2 Cells: Compound-Induced Analysis

figure s2 compound induced biomarker expression n.w
1 / 21
Embed
Share

Explore compound-induced biomarker expression in HepG2 cells with mean values and standard deviations from multiple experiments. Gene upregulation thresholds and fold change inductions are highlighted for various compounds including APAP, ASP, BPR, CBZ, CHL, DFN, FAM, and HYZ.

  • Biomarker Expression
  • HepG2 Cells
  • Compound-Induced Analysis
  • Gene Regulation
  • Fold Change

Uploaded on | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. Figure S2: Compound induced biomarker expression in HepG2 cells. The presented values (relative expression fold changes) represent mean values that were calculated from 3-5 independent experiments. The error bars illustrate the standard deviation of the independent experiments. A gene was considered to be up regulated when crossing the threshold line, which illustrates a significant increase of at least 2.5 fold change induction. APAP induced biomarker expression (n=4) HepG2 cells 6 5 Fold change 2 - CT 4 3 2 1 0 Concentration [mM] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  2. ASP induced biomarker expression (n=3) HepG2 cells 3 2.5 Fold change 2 - CT 2 1.5 1 0.5 0 Concentration [mM] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  3. BPR induced biomarker expression (n=3) HepG2 cells 4.5 4 Fold change 2 - CT 3.5 3 2.5 2 1.5 1 0.5 0 Concentration [nM] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  4. CBZ induced biomarker expression (n=3) HepG2 cells 25 Fold change 2 - CT 20 15 10 5 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  5. CHL induced biomarker expression (n=3) HepG2 cells 6 5 Fold change 2 - CT 4 3 2 1 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  6. DFN induced biomarker expression (n=3) HepG2 cells 7 6 Fold change 2 - CT 5 4 3 2 1 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  7. FAM induced biomarker expression (n=3) HepG2 cells 3 2.5 Fold change 2 - CT 2 1.5 1 0.5 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  8. HYZ induced biomarker expression (n=4) HepG2 cells 7 6 Fold change 2 - CT 5 4 3 2 1 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  9. INAH induced biomarker expression (n=4) HepG2 cells 7 6 Fold change 2 - CT 5 4 3 2 1 0 Concentration [mM] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  10. LAB induced biomarker expression (n=3) HepG2 cells 3 2.5 Fold change 2 - CT 2 1.5 1 0.5 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  11. LEV induced biomarker expression (n=3) HepG2 cells 3 2.5 Fold change 2 - CT 2 1.5 1 0.5 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  12. MEL induced biomarker expression (n=3) HepG2 cells 3.5 3 Fold change 2 - CT 2.5 2 1.5 1 0.5 0 Concentration [nM] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  13. NFT induced biomarker expression (n=3) HepG2 cells 70 60 Fold change 2 - CT 50 40 30 20 10 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  14. NIM induced gene expression (n=3) HepG2 cells 20 18 Fold change 2 - CT 16 14 12 10 8 6 4 2 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  15. PhB induced biomarker expression (n=3) HepG2 cells 12 10 Fold change 2 - CT 8 6 4 2 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  16. PMZ induced biomarker expression (n=3) HepG2 cells 8 7 Fold change 2 - CT 6 5 4 3 2 1 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  17. PPL induced biomarker expression (n=3) HepG2 cells 9 8 Fold change 2 - CT 7 6 5 4 3 2 1 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  18. RIF induced biomarker expression (n=3) HepG2 cells 4.5 4 Fold change 2 - CT 3.5 3 2.5 2 1.5 1 0.5 0 Concentration [ M] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

  19. VPA induced biomarker expression (n=3) HepG2 cells 25 Fold change 2 - CT 20 15 10 5 0 Concentration [mM] CYP1B1 CYP3A7 Tubb2b SULT1C2 G6PD RGCC Fbxo32

Related


More Related Content